Adverse events are listed by agent below.

**Patisiran**

- Upper respiratory tract infections (URTI) (28%)

- Infusion-related reactions (19%)

- Dyspepsia (8%)

- Dyspnea (8%)

- Muscle spasms (8%)

- Arthralgia (7%)

- Erythema (7%)

- Bronchitis (7%)

- Vertigo (5%)

**Givosiran**

- Nausea (27%)

- Injection site reactions (25%)

- Rash (17%)

- Serum creatinine increase (15%)

- Elevated liver transaminases (13%)

- Fatigue (10%)

**Lumasiran**

- Injection site reactions (38%)

- Abdominal pain/discomfort (15%)

**Inclisiran**

- Arthralgia (4%)

- Urinary tract infection (3.6%)

- Diarrhea (3.5%)

- Bronchitis (2.7%)

- Pain in extremity (2.6%)

- Dyspnea (2.6%)

- Injection site reaction (1.8%)